Warning letter
Kabco, Inc.: warning letter of Sep 26, 2001
FDA warning letter UCM178721 · New York District Office
Key facts
| Reference number | UCM178721 |
|---|---|
| Company | Kabco, Inc. |
| Subject | Cholestrol Support Capsules/Unapproved New Drug Application/Misbranded |
| Issue date | Sep 26, 2001 |
| Posted date | Sep 26, 2001 |
| Issuing office | New York District Office |
| Product type | Drugs |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: